Abstract
Several challenges need to be overcome when applying nucleic acids as therapeutic agents. We developed a new way to control the onset of the release of cholesterol-conjugated oligonucleotides with a simple, versatile, and cheap platform. Moreover, we combine the platform into a dual-release system that can release a hydrophobic drug with zero-order kinetics, followed by a rapid release of cholesterol-conjugated DNA.
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 8099-8102 |
Seitenumfang | 4 |
Fachzeitschrift | Chemical Communications |
Jahrgang | 59 |
Ausgabenummer | 52 |
DOIs | |
Publikationsstatus | Veröffentlicht - 23 Mai 2023 |